Secukinumab in Refractory Generalized Darier’s Disease with a 40-Year Disease Duration: A Case Report
Clinical, Cosmetic and Investigational Dermatology · 2026-08 · Volume 19 · 1-7
DOI: 10.2147/ccid.s620845 ↗Kurz gefasst
Fallbericht in der Zeitschrift Clinical, Cosmetic and Investigational Dermatology, 2026-08. Verfasst von Yangfei Ou und 4 weiteren Autor:innen. Beteiligte Einrichtung: Drug Clinical Trial Institution Office, Suining Central Hospital, Suining, Sichuan, 629000, People's Republic of China. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Drug Clinical Trial Institution Office, Suining Central Hospital, Suining, Sichuan, 629000, People's Republic of China.
- Department of Dermatology, Suining Central Hospital, Suining, Sichuan, 629000, People's Republic of China.
ORCID-Profile: Hui Fang, Tingting Liu, Zongkun Cai, Li Cheng
Zitieren
APA
Ou, Y., Fang, H., Liu, T., Cai, Z., & Cheng, L. (2026). Secukinumab in Refractory Generalized Darier’s Disease with a 40-Year Disease Duration: A Case Report. Clinical, Cosmetic and Investigational Dermatology, Volume 19, 1-7. https://doi.org/10.2147/ccid.s620845
Vancouver
Ou Y, Fang H, Liu T, Cai Z, Cheng L. Secukinumab in Refractory Generalized Darier’s Disease with a 40-Year Disease Duration: A Case Report. Clinical, Cosmetic and Investigational Dermatology. 2026;Volume 19:1-7. doi:10.2147/ccid.s620845
BibTeX
@article{Ou2026,
author = {Ou, Yangfei and Fang, Hui and Liu, Tingting and Cai, Zongkun and Cheng, Li},
title = {Secukinumab in Refractory Generalized Darier’s Disease with a 40-Year Disease Duration: A Case Report},
journal = {Clinical, Cosmetic and Investigational Dermatology},
year = {2026},
volume = {Volume 19},
pages = {1--7},
doi = {10.2147/ccid.s620845}
}
EUVIMED